Literature DB >> 16431138

TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T.

Radhika Srinivasan1, Charles Cunningham, Albert Chen, Daniel Vigneron, Ralph Hurd, Sarah Nelson, Daniel Pelletier.   

Abstract

Glutamate and glutamine are important neurochemicals in the central nervous system and the neurotoxic properties of excess glutamate have been associated with several neurodegenerative diseases. The TE-Averaged PRESS technique has been shown by our group to detect an unobstructed glutamate signal at 3 T that is resolved from glutamine and NAA at 2.35 ppm. TE-Averaged PRESS therefore provides an unambiguous measurement of glutamate as well as other metabolites such as NAA, choline, creatine, and myo-inositol. In this study, we extend the single voxel TE-Averaged PRESS technique for two-dimensional (2D) spectroscopic imaging (TE-Averaged MRSI) to generate 2D glutamate maps. To facilitate TE-Averaged MRSI within a reasonable time, a fast encoding trajectory was used. This enabled rapid acquisition of TE-Averaged spectral arrays with good spectral bandwidth (977 Hz) and resolution (approximately 2 Hz). MRSI data arrays of 10 x 16 were acquired with 1.8 cm3 spatial resolution over a approximately 110 cm3 volume in a scan time of approximately 21 min. Two-dimensional metabolite maps were obtained with good SNR and clear differentiation in glutamate levels was observed between gray and white matter with significantly higher glutamate in gray matter relative to white matter as anticipated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16431138     DOI: 10.1016/j.neuroimage.2005.10.048

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  28 in total

1.  Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control.

Authors:  Liv E Falkenberg; René Westerhausen; Karsten Specht; Kenneth Hugdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 2.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

Review 3.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Fast multivoxel two-dimensional spectroscopic imaging at 3 T.

Authors:  Dong-Hyun Kim; Roland Henry; Daniel M Spielman
Journal:  Magn Reson Imaging       Date:  2007-04-05       Impact factor: 2.546

Review 5.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

6.  Regional distributions of brain glutamate and glutamine in normal subjects.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Andrew A Maudsley
Journal:  NMR Biomed       Date:  2016-06-28       Impact factor: 4.044

7.  Fast parallel spiral chemical shift imaging at 3T using iterative SENSE reconstruction.

Authors:  Dirk Mayer; Dong-Hyun Kim; Daniel M Spielman; Roland Bammer
Journal:  Magn Reson Med       Date:  2008-04       Impact factor: 4.668

8.  Regional and tissue-specific differences in brain glutamate concentration measured by in vivo single voxel MRS.

Authors:  Yan Zhang; Jun Shen
Journal:  J Neurosci Methods       Date:  2014-09-27       Impact factor: 2.390

9.  Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder.

Authors:  Tamar Kolodny; Michael-Paul Schallmo; Jennifer Gerdts; Richard A E Edden; Raphael A Bernier; Scott O Murray
Journal:  Autism Res       Date:  2020-04-16       Impact factor: 5.216

10.  Imaging of glutamate in the spinal cord using GluCEST.

Authors:  Feliks Kogan; Anup Singh; Catherine Debrosse; Mohammad Haris; Kejia Cai; Ravi Prakash Nanga; Mark Elliott; Hari Hariharan; Ravinder Reddy
Journal:  Neuroimage       Date:  2013-04-09       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.